Maxi Investments CY Ltd Invests $545,000 in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Key Points

• Maxi Investments CY Ltd has acquired 1,100 shares of Intuitive Surgical, Inc. (NASDAQ: ISRG) valued at approximately $545,000, marking a new investment during Q1.
• Multiple hedge funds have increased their positions in Intuitive Surgical, with 83.64% of the company's stock now owned by institutional investors.
• Analysts have mixed ratings on Intuitive Surgical, with one downgrade to "sell" and multiple upgrades to "buy," leading to a consensus rating of "Moderate Buy" and an average target price of $595.95.

Maxi Investments CY Ltd acquired a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the first quarter, according to its most recent disclosure with the SEC. The firm acquired 1,100 shares of the medical equipment provider's stock, valued at approximately $545,000.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Castleark Management LLC raised its stake in shares of Intuitive Surgical by 3.4% during the 4th quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider's stock worth $47,221,000 after buying an additional 2,990 shares in the last quarter. Arlington Trust Co LLC boosted its stake in shares of Intuitive Surgical by 34.5% in the first quarter. Arlington Trust Co LLC now owns 745 shares of the medical equipment provider's stock valued at $369,000 after buying an additional 191 shares in the last quarter. Aaron Wealth Advisors LLC grew its holdings in Intuitive Surgical by 3.2% during the first quarter. Aaron Wealth Advisors LLC now owns 2,509 shares of the medical equipment provider's stock worth $1,243,000 after acquiring an additional 78 shares during the period. Longbow Finance SA raised its position in Intuitive Surgical by 132.0% in the first quarter. Longbow Finance SA now owns 19,699 shares of the medical equipment provider's stock worth $9,756,000 after acquiring an additional 11,209 shares in the last quarter. Finally, Ewing Morris & Co. Investment Partners Ltd. purchased a new position in Intuitive Surgical in the fourth quarter worth $454,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Performance

Intuitive Surgical stock traded down $2.94 during trading on Wednesday, reaching $474.06. The company had a trading volume of 2,189,756 shares, compared to its average volume of 2,261,750. The firm has a market capitalization of $169.94 billion, a price-to-earnings ratio of 66.12, a PEG ratio of 5.00 and a beta of 1.59. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The stock's 50 day moving average price is $521.43 and its two-hundred day moving average price is $531.52.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%. The business had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. During the same period in the prior year, the firm posted $1.78 EPS. The business's revenue for the quarter was up 21.4% on a year-over-year basis. As a group, research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Activity

In related news, insider Gary S. Guthart sold 7,893 shares of the stock in a transaction that occurred on Monday, July 28th. The shares were sold at an average price of $498.64, for a total transaction of $3,935,765.52. Following the completion of the sale, the insider owned 13,187 shares of the company's stock, valued at approximately $6,575,565.68. This represents a 37.44% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Myriam Curet sold 4,500 shares of the firm's stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the transaction, the executive vice president owned 353 shares in the company, valued at $173,845.44. The trade was a 92.73% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 15,903 shares of company stock valued at $7,932,778 in the last three months. Corporate insiders own 0.70% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. BTIG Research boosted their target price on shares of Intuitive Surgical from $566.00 to $571.00 and gave the stock a "buy" rating in a research report on Wednesday, July 23rd. Evercore ISI boosted their price objective on shares of Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a report on Tuesday, July 8th. Royal Bank Of Canada raised their price objective on Intuitive Surgical from $605.00 to $615.00 and gave the company an "outperform" rating in a research note on Wednesday, July 23rd. UBS Group boosted their target price on Intuitive Surgical from $547.00 to $585.00 and gave the stock a "neutral" rating in a research report on Wednesday, July 23rd. Finally, Deutsche Bank Aktiengesellschaft cut Intuitive Surgical from a "hold" rating to a "sell" rating and dropped their price target for the company from $515.00 to $440.00 in a research report on Monday, June 9th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $595.95.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.